More recently in 2012 an International Task Force on ARDS-acute respiratory distress
syndrome has changed the terminology of acute respiratory disorders gathering several
terms in a single nomenclature, then TDGE-transient dysfunction of gas exchange was
abandoned[.
Thus, ARDS was categorized according to PaO2/FiO2 levels into
three degrees of hypoxemia: mild (200 to 300 mmHg), moderate (100 to 200 mmHg) and
severe (<100 mmHg).Rodrigues et al.[
focused on postoperative acute respiratory disorder concerning adult patients submitted
to cardiac surgery. In this retrospective cohort of 717 patients, they accounted for
over 60% of patients with moderate or important degree of hypoxemia as above-mentioned.
This considerable number of patients with respiratory impairment had an impact in
outcomes as ICU (Intensive Care Unit) length of stay and rose susceptibility to
pulmonary infection.Three risk factors were identified on multivariate analysis: renal replacement therapy
[P=0.0005, Odds ratio (OR) 2.34], cardiac arrhythmia
(P=0.045, OR 1.79) and blood transfusion
(P=0.0001, OR 1.72). Indeed, blood transfusion has been considered a
key point of TDGE, but in fact it is unduly burdensome.Certainly TRALI- transfusion-related acute lung injury is a well-known acronym used in
ICU settings by health personnel as well as TDGE[. There is also a widespread concerning about
reducing blood transfusion to prevent TRALI or ARDS or TDGE, hence decreasing
morbimortality rates[.
The etiology may be different for acute respiratory distress, but pathophysiology is
alike no matter which name is given.For practical purposes, several studies compared restrictive transfusion strategy < 7
g per dL of hemoglobin (class IIa-level of evidence C) versus a liberal transfusion
trigger of 10 g per dL of hemoglobin (class III-C). Some strategies have been used in
cardiac surgery as intraoperative auto-transfusion (class IIb-C), OPCABG (Off-Pump
Coronary Artery Bypass Graft) (class IIa-A), centrifugation of pump-salvaged blood
(class IIb-A), red cell savage (class I-A), minicircuits (class I-A), recombinant humanerythropoietin (class IIa-A) as other drugs and manoeuvres to prevent blood
loss[.READ ARTICLE ON PAGE 24Evidenced-based medicine pointed out the rationale to reduce the use of blood
products[.
Nonetheless, it should have a proper balance between transfusion therapy and "permissive
anemia", it also requires particularly careful on an individual case basis.In conclusion, ARDS is still a source of relevant morbimortality in cardiac surgery,
several risk factors have been intelligibly associated to, having a special focus on
blood transfusion further studies may help in achieving a gold standard guideline to
this complex issue.
Authors: Pearl Toy; Mark A Popovsky; Edward Abraham; Daniel R Ambruso; Leslie G Holness; Patricia M Kopko; Janice G McFarland; Avery B Nathens; Christopher C Silliman; David Stroncek Journal: Crit Care Med Date: 2005-04 Impact factor: 7.598
Authors: Victor A Ferraris; Jeremiah R Brown; George J Despotis; John W Hammon; T Brett Reece; Sibu P Saha; Howard K Song; Ellen R Clough; Linda J Shore-Lesserson; Lawrence T Goodnough; C David Mazer; Aryeh Shander; Mark Stafford-Smith; Jonathan Waters; Robert A Baker; Timothy A Dickinson; Daniel J FitzGerald; Donald S Likosky; Kenneth G Shann Journal: Ann Thorac Surg Date: 2011-03 Impact factor: 4.330
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272